Clinical Outcomes Following Stereotactic Body Radiation Therapy (SBRT) for Stage I Medically Inoperable Small Cell Lung Carcinoma: A Multi-Institutional Analysis From the RSSearch Patient Registry.
CONCLUSIONS: SBRT was well-tolerated in the treatment of stage I SCLC with excellent LC achieved. Patients with T1N0 stage IA SCLC were noted to have improved PFS and OS following SBRT as compared with T2N0 Stage IB SCLC. Adjuvant chemotherapy was found to result in improved OS for stage I SCLC patients over SBRT alone.
PMID: 31232723 [PubMed - in process]
Source: Clinical Lung Cancer - Category: Cancer & Oncology Authors: Singh R, Ansinelli H, Sharma D, Jenkins J, Davis J, Vargo JA, Sharma S Tags: Am J Clin Oncol Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Chemotherapy | Esophagus Cancer | Lung Cancer | Radiation Therapy | Small Cell Lung Cancer | Toxicology